(Q38241689)

2 July 2019

3 references

21 December 2019

26 January 2021

20 October 2022

The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach (English)

1 reference

2 July 2019

protein degradation end products

main subject

1 reference

21 December 2019

1 reference

neuroprotective agent

1 reference

26 January 2021

2

1 reference

2 July 2019

Rizwan Hasan Khan

series ordinal

3

1 reference

2 July 2019

author name string

Parveen Salahuddin

series ordinal

1

1 reference

2 July 2019

publication date

20 August 2014

1 reference

2 July 2019

Cellular & Molecular Biology Letters

1 September 2014

3 references

21 December 2019

26 January 2021

20 October 2022

4 references

2 July 2019

21 December 2019

26 January 2021

20 October 2022

19

1 reference

2 July 2019

issue

3

1 reference

2 July 2019

page(s)

407-437

1 reference

2 July 2019

https://scigraph.springernature.com/pub.10.2478/s11658-014-0205-5

exact match

0 references

cites work

Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycation end product level, diabetes, and accelerated cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycoxidation end products in commonly consumed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

A review on research progress of transketolase

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Glycoxidation and diabetic complications: modern lessons and a warning?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Involvement of Maillard reactions in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Fructosamine 3-kinase, an enzyme involved in protein deglycation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Isoferulic acid, a new anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Prions as adaptive conduits of memory and inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Naturally occurring phytochemicals for the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycation end products, diabetes, and the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Early AGEing and Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Role of advanced glycation end products in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

[Parkinson's disease: Role of genetic and environment factors. Involvement in everyday clinical practice].

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Protein glycation: a firm link to endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Recent advances in the genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Renoprotective effects of a novel inhibitor of advanced glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

A new perspective on thiamine catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Toxicity of glyoxals--role of oxidative stress, metabolic detoxification and thiamine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

A tombstone in Alzheimer's?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

The controversial protein-only hypothesis of prion propagation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-014-0205-5

Carbonyl Stress and Diabetic Complications

21 January 2018

1 reference

12 December 2020

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

1 reference

12 December 2020

Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia

1 reference

12 December 2020

Molecular enzymology of the glyoxalase system

1 reference

12 December 2020

Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species

1 reference

12 December 2020

Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?

1 reference

12 December 2020

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation

1 reference

12 December 2020

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

1 reference

12 December 2020

The effectiveness of putative anti-cataract agents in the prevention of protein glycation.

1 reference

12 December 2020

Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis

1 reference

12 December 2020

Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes

1 reference

12 December 2020

The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation

1 reference

12 December 2020

Increased protein glycation in fructosamine 3-kinase-deficient mice

1 reference

12 December 2020

1 reference

12 December 2020

Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease

1 reference

12 December 2020

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

1 reference

12 December 2020

Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits

1 reference

12 December 2020

Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases

1 reference

12 December 2020

Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration

1 reference

12 December 2020

Inhibition of Advanced Glycation End-Product Formation by Origanum majorana L. In Vitro and in Streptozotocin-Induced Diabetic Rats

1 reference

12 December 2020

Antioxidant and anti-AGE therapeutics: evaluation and perspectives

1 reference

12 December 2020

Rapid hydrolysis and slow α,β-dicarbonyl cleavage of an agent proposed to cleave glucose-derived protein cross-links

1 reference

12 December 2020

The sour side of neurodegenerative disorders: the effects of protein glycation.

1 reference

12 December 2020

Metformin reduces systemic methylglyoxal levels in type 2 diabetes

1 reference

12 December 2020

Influence of penicillamine on the formation of early non-enzymatic glycation products of human serum proteins

1 reference

12 December 2020

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

1 reference

12 December 2020

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

1 reference

12 December 2020

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

12 December 2020

Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity

1 reference

12 December 2020

Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury

1 reference

12 December 2020

Effect of micronutrients on methylglyoxal-mediated in vitro glycation of albumin

1 reference

12 December 2020

Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis

1 reference

12 December 2020

Binding studies of truncated variants of the Aβ peptide to the V-domain of the RAGE receptor reveal Aβ residues responsible for binding

1 reference

12 December 2020

Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo

1 reference

12 December 2020

Chelating activity of advanced glycation end-product inhibitors

1 reference

12 December 2020

Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal

1 reference

12 December 2020

Glycation stimulates amyloid formation

1 reference

12 December 2020

Role of advanced glycation on aggregation and DNA binding properties of α-synuclein.

1 reference

12 December 2020

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide

1 reference

12 December 2020

Carnosine, a protective, anti-ageing peptide?

1 reference

12 December 2020

Diabetes and advanced glycation endproducts

1 reference

12 December 2020

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

1 reference

12 December 2020

Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies

1 reference

12 December 2020

Metformin inhibition of glycation processes

1 reference

12 December 2020

Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Kinetin inhibits protein oxidation and glycoxidation in vitro

1 reference

12 December 2020

pH-Induced molten globule state of Rhizopus niveus lipase is more resistant against thermal and chemical denaturation than its native state

1 reference

12 December 2020

Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation.

1 reference

12 December 2020

Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.

1 reference

12 December 2020

Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation

1 reference

12 December 2020

pH-dependent conformational transitions in conalbumin (ovotransferrin), a metalloproteinase from hen egg white

1 reference

12 December 2020

Genistein inhibits advanced glycation end product formation by trapping methylglyoxal

1 reference

12 December 2020

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex

1 reference

12 December 2020

Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.

1 reference

12 December 2020

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

1 reference

12 December 2020

The impact of genetic research on our understanding of Parkinson's disease

1 reference

12 December 2020

Prion protein and its role in signal transduction

1 reference

12 December 2020

Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia

1 reference

12 December 2020

Glycation exacerbates the neuronal toxicity of β-amyloid.

1 reference

12 December 2020

Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats

1 reference

12 December 2020

CD36, serves as a receptor for advanced glycation endproducts (AGE)

1 reference

12 December 2020

AGEs in foods: Do they play a role in uremia?

1 reference

12 December 2020

Methylglyoxal, cognitive function and cerebral atrophy in older people.

1 reference

12 December 2020

Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors

1 reference

12 December 2020

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

1 reference

12 December 2020

Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain.

1 reference

12 December 2020

The mechanism of thiamine action: predictions from model experiments

1 reference

12 December 2020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

12 December 2020

Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine

1 reference

12 December 2020

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

1 reference

12 December 2020

Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.

1 reference

12 December 2020

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

1 reference

12 December 2020

Studies on absorption and elimination of dietary maillard reaction products

1 reference

12 December 2020

Protein glycation, diabetes, and aging

1 reference

12 December 2020

Glycation of human serum albumin: inhibition by Diclofenac

1 reference

12 December 2020

Dementia: a brief review

1 reference

12 December 2020

Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease

1 reference

12 December 2020

Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin

1 reference

12 December 2020

Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction

1 reference

12 December 2020

Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats

1 reference

12 December 2020

2,3-Dimethoxy-5-methyl-1,4-benzoquinones and 2-methyl-1,4-naphthoquinones: glycation inhibitors with lipid peroxidation activity

1 reference

12 December 2020

Genetics of familial and sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Synthesis of a novel radical trapping and carbonyl group trapping anti-AGE agent: a pyridoxamine analogue for inhibiting advanced glycation (AGE) and lipoxidation (ALE) end products

1 reference

12 December 2020

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

1 reference

12 December 2020

Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

1 reference

12 December 2020

10.2478/S11658-014-0205-5

Identifiers

DOI

1 reference

2 July 2019

Dimensions Publication ID

0 references

1 reference

2 July 2019

PubMed ID

25141979

1 reference

2 July 2019